Related Experiment Video
Updated: Aug 17, 2026

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
Published on: November 13, 2012
Clinical cancer chronotherapy trials: a review
1Department of Medicine, University of Toronto, Ontario, Canada.
Abstract:
Experimental studies have documented that both toxicity and antitumor activity of cancer drugs are time dependent. The mechanism behind this observation is at least in part related to circadian changes in pharmacokinetics, pharmacodynamics, and DNA synthesis in both normal organs and tumors. The results of published studies designed to test chronotherapy in cancer patients are reviewed. The possible mechanisms behind the circadian-stage-dependent pharmacokinetics and pharmacodynamics are reviewed briefly for all drug classes but in detail for the fluoropyrimidines. Clinical trials have confirmed that both toxicity and achievable dose intensity for several cancer drugs are time dependent. Ongoing prospective randomized studies will determine whether this scheduling method impacts on response rate and overall survival in cancer patients.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
04:11A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
Published on: June 9, 2026
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...